BieGene

A month after multi-billion dollar Novartis deal, BeiGene follows up with 'reverse' deal
Endpoints
Thu, 02/18/21 - 10:40 am
BieGene
Novartis
Boston Immune Technologies
TNFR2
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
Xconomy
Fri, 01/11/19 - 09:58 am
Celgene
M&A
Juno Therapeutics
Kite Therapeutics
Bluebird Bio
Agios Pharmaceuticals
Jounce Therapeutics
BieGene
Acceleron